COST-EFFECTIVENESS ANALYSIS FOR TREATMENT OF PARKINSON'S DISEASE: A SYSTEMATIC REVIEW

被引：0
|
作者：
Yamabe, K. [1 ]
Inoue, S. [2 ]
Kuwabara, H. [1 ]
Kobayashi, M. [2 ]
机构：
[1] Takeda Pharmaceut Co Ltd, Tokyo, Japan
[2] CRECON Med Assessment Inc, Tokyo, Japan
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 07期
关键词：
D O I：
10.1016/j.jval.2016.09.497
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND43
引用
收藏
页码：A432 / A432
页数：1
相关论文
共 50 条
  • [1] Devices for remote continuous monitoring of people with Parkinson's disease: a systematic review and cost-effectiveness analysis
    Cox, Edward
    Wade, Ros
    Hodgson, Robert
    Fulbright, Helen
    Phung, Thai Han
    Meader, Nicholas
    Walker, Simon
    Rothery, Claire
    Simmonds, Mark
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2024, 28 (30)
  • [2] Cost-effectiveness analysis of dopamine agonists in the treatment of Parkinson's disease in Japan
    Shimbo, T
    Hira, K
    Takemura, M
    Fukui, T
    [J]. PHARMACOECONOMICS, 2001, 19 (08) : 875 - 886
  • [3] Deep brain stimulation in the treatment of Parkinson's disease - A cost-effectiveness analysis
    Tomaszewski, KJ
    Holloway, RG
    [J]. NEUROLOGY, 2001, 57 (04) : 663 - 671
  • [4] Cost-Effectiveness Analysis of Dopamine Agonists in the Treatment of Parkinson’s Disease in Japan
    Takuro Shimbo
    Kenji Hira
    Manabu Takemura
    Tsuguya Fukui
    [J]. PharmacoEconomics, 2001, 19 : 875 - 886
  • [5] Cost-effectiveness analysis of pramipexole in early Parkinson's disease
    Noyes, K
    Dick, AW
    Holloway, RG
    [J]. VALUE IN HEALTH, 2003, 6 (03) : 274 - 274
  • [6] Cost-effectiveness analysis of spa therapy in Parkinson's disease
    Brefel-Courbon, C
    Desboeuf, K
    Thalamas, C
    Galitzky, M
    Senard, JM
    Rascol, O
    [J]. MOVEMENT DISORDERS, 2002, 17 : S73 - S73
  • [7] Cost-effectiveness of measles treatment: a systematic review
    Nam Xuan Vo
    Anh Thi Van Nguyen
    Ha Thi Mai Tran
    Linh Thi Thuy Truong
    Nghi Ngoc Bao Nguyen
    [J]. JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2019, 69 (06) : S148 - S154
  • [8] COST-EFFECTIVENESS ANALYSIS OF A HYPOTHETICAL DISEASE MODIFYING THERAPY FOR PARKINSON'S DISEASE
    Chandler, C.
    Gal, P.
    Folse, H.
    Chavan, A.
    Ward, A.
    [J]. VALUE IN HEALTH, 2020, 23 : S633 - S633
  • [9] Cost-effectiveness analysis in Parkinson's disease: Determining the value of interventions
    Siderowf, AD
    Holloway, RG
    Stern, MB
    [J]. MOVEMENT DISORDERS, 2000, 15 (03) : 439 - 445
  • [10] Exercise for falls prevention in Parkinson's disease: A cost-effectiveness analysis
    Farag, I.
    Howard, K.
    Hayes, A.
    Canning, C. G.
    Fung, V. S. C.
    Sherrington, C.
    [J]. MOVEMENT DISORDERS, 2014, 29 : S237 - S237
12345